Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Mar 15, 2020; 12(3): 248-266
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.248
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.248
Study | Year | Country | Patients | Study Design | Surgical management | Outcome | Duration of follow up |
Bachman et al[68] | 2003 | Switzerland | 1 | Case report | Selective hepatic artery ligation | Stable, asymptomatic, heart failure signs disappeared | 48 mo |
Bostancı et al[65] | 2014 | Turkey | 1 | Case report | Selective internal radiotherapy | Partial response | 12 mo |
Grotz et al[57] | 2010 | United States | 11/30 | Retrospective | Hepatic resection | A 1-, 3- and 5-year overall survival of 100%, 86% and 86% and a disease free survival of 78%, 62% and 62%, respectively | 60 mo |
Wang et al[88] | 2012 | China | 17/33 | Retrospective | Hepatic resection | No significant difference in overall survival between the 17 patients who underwent liver resection alone 3-year survival rate 74.1% | 1 patient underwent liver transplant and died 12 mo post-transplant |
- Citation: Virarkar M, Saleh M, Diab R, Taggart M, Bhargava P, Bhosale P. Hepatic Hemangioendothelioma: An update. World J Gastrointest Oncol 2020; 12(3): 248-266
- URL: https://www.wjgnet.com/1948-5204/full/v12/i3/248.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i3.248